Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | +10.13% | +18.92% | +32.23% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 56.17M |
---|---|---|---|---|---|
Net income 2022 | -15M | Net income 2023 | -17M | EV / Sales 2022 | - |
Net cash position 2022 | 17.76M | Net cash position 2023 | 936K | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.95
x | P/E ratio 2023 |
-3.29
x | Employees | 9 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.56% |
Latest transcript on Tiziana Life Sciences Ltd
1 day | +7.24% | ||
1 week | +6.41% | ||
Current month | +3.68% | ||
1 month | +23.71% | ||
3 months | +30.96% | ||
6 months | +23.82% | ||
Current year | +21.61% |
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.75 | +10.13% | 84 442 |
24-05-16 | 0.681 | +7.24% | 157,240 |
24-05-15 | 0.635 | +12.85% | 184,689 |
24-05-14 | 0.5627 | -8.00% | 129,371 |
24-05-13 | 0.6116 | -1.78% | 95,628 |
Delayed Quote Nasdaq, May 16, 2024 at 04:30 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.61% | 68.31M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.17% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- TLSA Stock